MARK4 inhibits Hippo signaling to promote proliferation and migration of breast cancer cells

No abstract is available for this paper.

• Publication year

  2017

• Venue

  EMBO Reports

• Publication date

  2017-02-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.15252/embr.201642455PMID 28183853PMCID PMC5331264
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MARK4 inhibits Hippo signaling to promote proliferation and migration of breast cancer cells

  2017cited by this paper
• Mechanisms of Hippo pathway regulation

  2016cited by this paper
• Control of YAP/TAZ Activity by Metabolic and Nutrient-Sensing Pathways.

  2016cited by this paper
• miR‐515‐5p controls cancer cell migration through MARK4 regulation

  2016cited by this paper
• AMPK modulates Hippo pathway activity to regulate energy homeostasis

  2015cited by this paper
• Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway

  2015cited by this paper
• Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division

  2015cited by this paper
• Genome engineering using CRISPR-Cas9 system.

  2015cited by this paper
• Aerobic glycolysis tunes YAP/TAZ transcriptional activity

  2015cited by this paper
• Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer.

  2015influential reference
• Metabolic control of YAP and TAZ by the mevalonate pathway

  2014cited by this paper
• The biology of YAP/TAZ: hippo signaling and beyond.

  2014cited by this paper
• Energy stress regulates hippo-YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein.

  2014cited by this paper
• The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease

  2014cited by this paper
• Arhgef7 promotes activation of the Hippo pathway core kinase Lats

  2014influential reference
• DNA targeting specificity of RNA-guided Cas9 nucleases

  2013cited by this paper
• A genetic screen identifies an LKB1–MARK signalling axis controlling the Hippo–YAP pathway

  2013cited by this paper
• The Hippo pathway and human cancer

  2013influential reference
• Polarity-dependent distribution of angiomotin localizes Hippo signaling in preimplantation embryos.

  2013cited by this paper
• Microtubule Affinity-Regulating Kinase 4: Structure, Function, and Regulation

  2013cited by this paper
• Par-1 Regulates Tissue Growth by Influencing Hippo Phosphorylation Status and Hippo-Salvador Association

  2013influential reference
• Genome engineering using the CRISPR-Cas9 system

  2013cited by this paper
• Protein Interaction Network of the Mammalian Hippo Pathway Reveals Mechanisms of Kinase-Phosphatase Interactions

  2013influential reference
• Regulation of the Hippo pathway by cell architecture and mechanical signals.

  2012cited by this paper
• Salt-inducible kinases regulate growth through the Hippo signalling pathway in Drosophila

  2012cited by this paper
• Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling.

  2012cited by this paper
• Integration of intercellular signaling through the Hippo pathway.

  2012cited by this paper
• The Hippo signaling pathway and stem cell biology.

  2012cited by this paper
• Protein kinases of the Hippo pathway: regulation and substrates.

  2012cited by this paper
• Inhibition of Tankyrases Induces Axin Stabilization and Blocks Wnt Signalling in Breast Cancer Cells

  2012cited by this paper
• Hippo signaling: growth control and beyond

  2011influential reference
• E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components

  2011cited by this paper
• The AMPK signalling pathway coordinates cell growth, autophagy and metabolism

  2011cited by this paper
• Hippo pathway regulation by cell morphology and stress fibers

  2011cited by this paper
• The Hippo pathway and apico-basal cell polarity.

  2011cited by this paper
• Phosphorylation of SAV1 by mammalian ste20-like kinase promotes cell death.

  2011cited by this paper
• Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance

  2011cited by this paper
• Role of YAP/TAZ in mechanotransduction

  2011cited by this paper
• Mst 1 and Mst 2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap 1 Oncogene

  2011cited by this paper
• The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells.

  2011cited by this paper
• Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver

  2010cited by this paper
• The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals.

  2010cited by this paper
• The Hippo–Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis

  2010cited by this paper
• The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program.

  2010cited by this paper
• The hippo signaling pathway in development and cancer.

  2010influential reference
• The Hippo pathway regulates Wnt/beta-catenin signaling.

  2010cited by this paper
• The skinny on Fat: an enormous cadherin that regulates cell adhesion, tissue growth, and planar cell polarity.

  2009cited by this paper
• The LKB1–AMPK pathway: metabolism and growth control in tumour suppression

  2009cited by this paper
• Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.

  2009cited by this paper
• Application of an integrated physical and functional screening approach to identify inhibitors of the Wnt pathway

  2009cited by this paper
• The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network

  2007cited by this paper
• The Par-1/MARK Family of Protein Kinases: From Polarity to Metabolism

  2007cited by this paper
• The Drosophila RASSF Homolog Antagonizes the Hippo Pathway

  2006cited by this paper
• High-Throughput Mapping of a Dynamic Signaling Network in Mammalian Cells

  2005cited by this paper
• An overview of the KIN1/PAR‐1/MARK kinase family

  2004cited by this paper
• hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts.

  2003cited by this paper
• MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption.

  1997cited by this paper
• A Elicits Apoptosis through an MST 2 Pathway Directing Proapoptotic Transcription by the p 73 Tumor Suppressor Protein

  year unknowncited by this paper

• A dual pH/ROS-sensitive nanoplatform blocking NETs formation and co-delivering paclitaxel for potent therapeutic efficacy against triple-negative breast cancer and lung metastasis.

  2026cites this paper
• Therapeutic Insights of Indole Scaffold‐Based Compounds as Protein Kinase Inhibitors

  2025cites this paper
• Mechanistic insights into the inhibition of microtubule affinity-regulating kinase 4 by Syringic acid: A computational and experimental study.

  2025cites this paper
• Atypical Hippo signaling network: uncovering novel insights into head and neck cancer biology and advancements in precision intervention

  2025cites this paper
• Hyperacute response proteins synthesized on γ-tubulin-FTO-MARK4 translation microdomains regulate cancer's acute stress response.

  2025cites this paper
• Targeting the Hippo pathway in cancer

  2025cites this paper
• Integrative High-Throughput RNAi Screening Identifies BRSK1, STK32C and STK40 as Novel Activators of YAP/TAZ

  2025cites this paper
• The ARK side of the cell: Kinases, metabolism, and therapeutic potential in malignancies.

  2025cites this paper
• Mechanosensor YAP mediates bone remodeling via NF-κB p65 induced osteoclastogenesis during orthodontic tooth movement

  2025cites this paper
• Mark3 a Prognostic Marker for the Endometrial Cancer

  2025cites this paper
• MARK4 promotes the malignant phenotype of gastric cancer through the MAPK/ERK signaling pathway.

  2024cites this paper
• Function of a complex of p‐Y42 RhoA GTPase and pyruvate kinase M2 in EGF signaling pathway in glioma cells

  2024cites this paper
• Vanillin-Isatin Hybrid-Induced MARK4 Inhibition As a Promising Therapeutic Strategy against Hepatocellular Carcinoma

  2024cites this paper
• Breast cancer drug resistance: Decoding the roles of Hippo pathway crosstalk.

  2024cites this paper
• MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer

  2024cites this paper
• Harnessing memantine in Alzheimer's disease therapy through inhibition of microtubule affinity-regulating kinase: Mechanistic insights.

  2024cites this paper
• Association Study between SNPs in MST1 and MST2 and H. pylori Infection as well as Noncardia Gastric Carcinogenesis

  2024cites this paper
• Interaction of Sp1 and Setd8 promotes vascular smooth muscle cells apoptosis by activating Mark4 in vascular calcification

  2024cites this paper
• GPR137 inactivates Hippo signaling to promote gastric cancer cell malignancy

  2024cites this paper
• New Insights into YAP/TAZ-TEAD-Mediated Gene Regulation and Biological Processes in Cancer

  2023cites this paper
• Multiomics dynamic learning enables personalized diagnosis and prognosis for pancancer and cancer subtypes

  2023cites this paper
• A cell-penetrating peptide derived from SARS-CoV-2 protein Orf9b allosterically inhibits MARK4 activity and mitigates tau toxicity.

  2023cites this paper
• SPTAN1/NUMB axis senses cell density to restrain cell growth and oncogenesis through Hippo signaling

  2023cites this paper
• Mechanistic insights into MARK4 inhibition by galantamine toward therapeutic targeting of Alzheimer’s disease

  2023cites this paper
• Therapeutic targeting of microtubule affinity‐regulating kinase 4 in cancer and neurodegenerative diseases

  2023influential citation
• DNAJB4 suppresses breast cancer progression and promotes tumor immunity by regulating the Hippo signaling pathway

  2023cites this paper
• Structure-guided design and development of vanillin-triazole conjugates as potential MARK4 inhibitors targeting hepatocellular carcinoma

  2023cites this paper
• Investigating role of plumbagin in preventing neurodegenerative diseases via inhibiting microtubule affinity regulating kinase 4

  2023cites this paper
• Synthesis, Structural Modification, and Bioactivity Evaluation of Substituted Acridones as Potent Microtubule Affinity-Regulating Kinase 4 Inhibitors.

  2023cites this paper
• Neutrophil extracellular traps mediate TLR9/Merlin axis to resist ferroptosis and promote triple negative breast cancer progression

  2023cites this paper
• Investigating MARK4 inhibitory potential of Bacopaside II: Targeting Alzheimer's disease.

  2023cites this paper
• Discovery of medicinal herbal compounds with potential anti-cancer activities against microtubule affinity-regulating kinase (MARK4) in cancer therapy

  2023cites this paper
• Advances of antitumor drug discovery in traditional Chinese medicine and natural active products by using multi‐active components combination

  2023cites this paper
• Differential Chemoproteomics Reveals MARK2/3 as Cell Migration‐Relevant Targets of the ALK Inhibitor Brigatinib

  2023cites this paper
• Inhibition of microtubule affinity regulating kinase 4 by an acetylcholinesterase inhibitor, Huperzine A: Computational and experimental approaches.

  2023cites this paper
• Molecular Pathways of Rosmarinic Acid Anticancer Activity in Triple-Negative Breast Cancer Cells: A Literature Review

  2023cites this paper
• The metabolic stress-activated checkpoint LKB1-MARK3 axis acts as a tumor suppressor in high-grade serous ovarian carcinoma

  2022cites this paper
• Characterizing Genes associated with Cancer using the CRISPR/Cas9 System: A Systematic Review of Genes and Methodological Approaches.

  2022cites this paper
• Shear stress regulates the migration of suspended breast cancer cells by nuclear lamina protein A/C and large tumor suppressor through yes-associated protein

  2022cites this paper
• KMT5A-methylated SNIP1 promotes triple-negative breast cancer metastasis by activating YAP signaling

  2022cites this paper
• System-wide health risk prediction for 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene(MBP), a major active metabolite of environmental pollutant and food contaminant - bisphenol A.

  2022cites this paper
• Targeting inhibition of microtubule affinity regulating kinase 4 by Harmaline: Strategy to combat Alzheimer's disease.

  2022cites this paper
• Emerging role of microtubule-associated proteins on cancer metastasis

  2022cites this paper
• Synthesis and biological activity of bisindole derivatives as novel MARK4 inhibitors

  2022cites this paper
• Microtubule-affinity regulating kinase 4: A potential drug target for cancer therapy.

  2022cites this paper
• YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma

  2022cites this paper
• A Network-Guided Approach to Discover Phytochemical-Based Anticancer Therapy: Targeting MARK4 for Hepatocellular Carcinoma

  2022cites this paper
• Clinical potential of the Hippo-YAP pathway in bladder cancer

  2022cites this paper
• MARK2 regulates chemotherapeutic responses through class IIa HDAC-YAP axis in pancreatic cancer

  2022cites this paper
• Targeting Microtubules for the Treatment of Heart Disease

  2022cites this paper
• Nitroimidazoles Part 10. Synthesis, crystal structure, molecular docking, and anticancer evaluation of 4-nitroimidazole derivatives combined with piperazine moiety

  2022cites this paper
• KMT5A-methylated SNIP1 promotes triple-negative breast cancer metastasis by activating YAP signaling

  2022cites this paper
• Phosphorylation analysis of the Hippo-YAP pathway using Phos-tag.

  2022cites this paper
• The Signaling Pathways Associated With Breast Cancer Bone Metastasis

  2022cites this paper
• MARK2/4 promotes Warburg effect and cell growth in non-small cell lung carcinoma through the AMPKα1/mTOR/HIF-1α signaling pathway.

  2022cites this paper
• In Situ Cell Signalling of the Hippo-YAP/TAZ Pathway in Reaction to Complex Dynamic Loading in an Intervertebral Disc Organ Culture

  2021cites this paper
• Advances in Understanding the LncRNA-Mediated Regulation of the Hippo Pathway in Cancer

  2021cites this paper
• Long non-coding RNA DLGAP1-AS1 promotes the progression of gastric cancer via miR-515-5p/MARK4 axis

  2021cites this paper
• New Insights into the Therapeutic Applications of CRISPR/Cas9 Genome Editing in Breast Cancer

  2021cites this paper
• Comprehensive profiling of novel epithelial–mesenchymal transition mediators and their clinical significance in colorectal cancer

  2021cites this paper
• Structure‐based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseases

  2021cites this paper
• Design, synthesis, and biological evaluation of novel benzimidazole derivatives as sphingosine kinase 1 inhibitor

  2021cites this paper
• Microtubule affinity regulating kinase 4: A promising target in the pathogenesis of atherosclerosis

  2021cites this paper
• Novel possibility for cutaneous melanoma treatment by means of rosmarinic acid action on purinergic signaling

  2021cites this paper
• Myricetin inhibits breast and lung cancer cells proliferation via inhibiting MARK4

  2021cites this paper
• OTT_A_283157 2397..2415

  2021cites this paper
• Hippo/TEAD4 signaling pathway as a potential target for the treatment of breast cancer

  2021cites this paper
• Design and Development of Small-Molecule Arylaldoxime/5-Nitroimidazole Hybrids as Potent Inhibitors of MARK4: A Promising Approach for Target-Based Cancer Therapy

  2020cites this paper
• Determination of the migration effect and molecular docking of verteporfin in different subtypes of breast cancer cells

  2020cites this paper
• Rosmarinic Acid Exhibits Anticancer Effects via MARK4 Inhibition

  2020cites this paper
• Discovery of 4-(2-(dimethylamino)ethoxy)benzohydrazide derivatives as prospective microtubule affinity regulating kinase 4 inhibitors

  2020cites this paper
• Identification of morpholine based hydroxylamine analogues: selective inhibitors of MARK4/Par-1d causing cancer cell death through apoptosis

  2020cites this paper
• A Potential Role of YAP/TAZ in the Interplay Between Metastasis and Metabolic Alterations

  2020cites this paper
• The Role of the Hippo Pathway in Breast Cancer Carcinogenesis, Prognosis, and Treatment: A Systematic Review

  2020cites this paper
• Hyaluronan Degradation Promotes Cancer via Hippo‐YAP Signaling: An Intervention Point for Cancer Therapy

  2020cites this paper
• MST2 silencing induces apoptosis and inhibits tumor growth for estrogen receptor alpha-positive MCF-7 breast cancer.

  2020cites this paper
• MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer’s Disease Therapy

  2020cites this paper
• Identification and genomic analysis of pedigrees with exceptional longevity identifies candidate rare variants.

  2020cites this paper
• Suberoylanilide Hydroxamic Acid Attenuates Interleukin-1β-Induced Interleukin-6 Upregulation by Inhibiting the Microtubule Affinity-Regulating Kinase 4/Nuclear Factor-κB Pathway in Synovium-Derived Mesenchymal Stem Cells from the Temporomandibular Joint

  2020cites this paper
• Colorectal cancer (CRC) as a multifactorial disease and its causal correlations with multiple signaling pathways

  2020cites this paper
• YAP/TAZ functions and their regulation at a glance

  2020cites this paper
• Two‐stage Bayesian GWAS of 9576 individuals identifies SNP regions that are targeted by miRNAs inversely expressed in Alzheimer's and cancer

  2020cites this paper
• Design and development of Isatin-triazole hydrazones as potential inhibitors of microtubule affinity-regulating kinase 4 for the therapeutic management of cell proliferation and metastasis.

  2019cites this paper
• Regulation of Hippo Signaling by Mechanical Signals and the Cytoskeleton

  2019cites this paper
• Evaluation of binding and inhibition mechanism of dietary phytochemicals with sphingosine kinase 1: Towards targeted anticancer therapy

  2019cites this paper
• Mark1 regulates distal airspace expansion through type I pneumocyte flattening in lung development

  2019cites this paper
• LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway

  2019cites this paper
• PCC0208017, a novel small-molecule inhibitor of MARK3/MARK4, suppresses glioma progression in vitro and in vivo

  2019cites this paper
• Hippo signalling during development

  2019cites this paper
• Identification of α-Mangostin as a Potential Inhibitor of Microtubule Affinity Regulating Kinase 4.

  2019cites this paper
• Discovery of Coumarin as Microtubule Affinity-Regulating Kinase 4 Inhibitor That Sensitize Hepatocellular Carcinoma to Paclitaxel

  2019cites this paper
• High-Molecular-Weight Hyaluronan Is a Hippo Pathway Ligand Directing Cell Density-Dependent Growth Inhibition via PAR1b.

  2019cites this paper
• miR‐664a‐3p functions as an oncogene by targeting Hippo pathway in the development of gastric cancer

  2019cites this paper
• CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment.

  2019cites this paper
• SALMON: Survival Analysis Learning With Multi-Omics Neural Networks on Breast Cancer

  2019cites this paper
• Probing the Inhibition of Microtubule Affinity Regulating Kinase 4 by N-Substituted Acridones

  2019cites this paper
• Yes‐associated protein promotes cell migration via activating Wiskott‐Aldrich syndrome protein family member 1 in oral squamous cell carcinoma

  2019cites this paper
• Luciferase Reporter Assays to Determine YAP/TAZ Activity in Mammalian Cells.

  2019cites this paper
• Regulation of YAP/TAZ Activity by Mechanical Cues: An Experimental Overview.

  2019cites this paper
• Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4)

  2019cites this paper